Financhill
Buy
69

WDC Quote, Financials, Valuation and Earnings

Last price:
$199.41
Seasonality move :
15.87%
Day range:
$188.36 - $221.23
52-week range:
$28.83 - $221.23
Dividend yield:
0.15%
P/E ratio:
31.99x
P/S ratio:
6.64x
P/B ratio:
12.74x
Volume:
17.2M
Avg. volume:
7.8M
1-year change:
342.24%
Market cap:
$75B
Revenue:
$9.5B
EPS (TTM):
$6.86
Period Ending 2021-06-30 2022-06-30 2023-06-30 2024-06-30 2025-06-30
Revenue $16.9B $18.8B $12.3B $6.3B $9.5B
Revenue Growth (YoY) 1.11% 11.06% -34.45% -48.72% 50.7%
 
Cost of Revenues $12.3B $12.6B $10.1B $4.3B $5.7B
Gross Profit $4.6B $6.2B $2.2B $2B $3.8B
Gross Profit Margin 27.17% 32.83% 18.25% 31.93% 40.35%
 
R&D Expenses $2.2B $2.3B $2B $950M $994M
Selling, General & Admin $1.1B $1.1B $970M $828M $568M
Other Inc / (Exp) $73M $35M -$170M -$493M $204M
Operating Expenses $3.3B $3.4B $3B $1.7B $1.6B
Operating Income $1.3B $2.7B -$731M $341M $2.3B
 
Net Interest Expenses $276M $179M $322M $414M $357M
EBT. Incl. Unusual Items $927M $2.1B -$1.6B -$739M $1.1B
Earnings of Discontinued Ops. -- -- -- -$33M $246M
Income Tax Expense $106M $623M $134M $26M -$513M
Net Income to Company $821M $1.5B -$1.7B -$798M $1.9B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $821M $1.5B -$1.7B -$765M $1.6B
 
Basic EPS (Cont. Ops) $2.69 $4.81 -$5.37 -$2.61 $4.99
Diluted EPS (Cont. Ops) $2.66 $4.75 -$5.37 -$2.61 $4.82
Weighted Average Basic Share $305M $312M $318M $326M $347M
Weighted Average Diluted Share $309M $316M $318M $326M $359M
 
EBITDA $2.5B $3.7B $97M $688M $2.6B
EBIT $1.3B $2.7B -$731M $341M $2.3B
 
Revenue (Reported) $16.9B $18.8B $12.3B $6.3B $9.5B
Operating Income (Reported) $1.3B $2.7B -$731M $341M $2.3B
Operating Income (Adjusted) $1.3B $2.7B -$731M $341M $2.3B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $5.1B $3.7B $2.8B $2.2B $2.8B
Revenue Growth (YoY) 28.79% -26.03% -26.39% -19.56% 27.4%
 
Cost of Revenues $3.3B $2.7B $2.6B $1.4B $1.6B
Gross Profit $1.8B $1B $179M $806M $1.2B
Gross Profit Margin 34.81% 27.92% 6.51% 36.44% 43.44%
 
R&D Expenses $578M $552M $431M $262M $294M
Selling, General & Admin $291M $247M $207M $242M $138M
Other Inc / (Exp) -$16M -$30M -$53M -$72M --
Operating Expenses $869M $799M $638M $466M $432M
Operating Income $889M $244M -$459M $340M $792M
 
Net Interest Expenses $66M $68M $98M $99M $59M
EBT. Incl. Unusual Items $704M $84M -$682M $243M $1.3B
Earnings of Discontinued Ops. -- -- -- $340M --
Income Tax Expense $94M $57M $3M $90M $155M
Net Income to Company $610M $27M -$685M $493M $1.2B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $610M $27M -$685M $151M $1.2B
 
Basic EPS (Cont. Ops) $1.97 $0.09 -$2.17 $1.42 $3.34
Diluted EPS (Cont. Ops) $1.93 $0.08 -$2.17 $1.37 $3.07
Weighted Average Basic Share $310M $316M $323M $344M $345M
Weighted Average Diluted Share $316M $319M $323M $357M $376M
 
EBITDA $1.1B $460M -$312M $475M $880M
EBIT $889M $244M -$459M $340M $792M
 
Revenue (Reported) $5.1B $3.7B $2.8B $2.2B $2.8B
Operating Income (Reported) $889M $244M -$459M $340M $792M
Operating Income (Adjusted) $889M $244M -$459M $340M $792M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $18.1B $17.5B $11.3B $9B $12B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $12.6B $12B $9.8B $6.2B $7.3B
Gross Profit $5.5B $5.5B $1.5B $2.8B $4.7B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $2.3B $2.3B $1.9B $1.2B $1.3B
Selling, General & Admin $1.1B $1.1B $930M $863M $608M
Other Inc / (Exp) $71M $21M -$202M -$480M --
Operating Expenses $3.4B $3.4B $2.8B $2B $1.9B
Operating Income $2.1B $2.1B -$1.3B $780M $2.8B
 
Net Interest Expenses $282M $269M $346M $417M $319M
EBT. Incl. Unusual Items $1.6B $1.5B -$2.3B -$221M $2.5B
Earnings of Discontinued Ops. -- -- -- $768M -$222M
Income Tax Expense $143M $586M $91M $167M -$301M
Net Income to Company $1.5B $917M -$2.4B $380M $2.6B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $1.5B $917M -$2.4B -$389M $2.8B
 
Basic EPS (Cont. Ops) $4.84 $2.93 -$7.66 $0.95 $7.25
Diluted EPS (Cont. Ops) $4.74 $2.90 -$7.66 $0.89 $6.86
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $3.2B $3B -$534M $1.3B $3.2B
EBIT $2.1B $2.1B -$1.3B $780M $2.8B
 
Revenue (Reported) $18.1B $17.5B $11.3B $9B $12B
Operating Income (Reported) $2.1B $2.1B -$1.3B $780M $2.8B
Operating Income (Adjusted) $2.1B $2.1B -$1.3B $780M $2.8B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $5.1B $3.7B $2.8B $2.2B $2.8B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $3.3B $2.7B $2.6B $1.4B $1.6B
Gross Profit $1.8B $1B $179M $806M $1.2B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $578M $552M $431M $262M $294M
Selling, General & Admin $291M $247M $207M $242M $138M
Other Inc / (Exp) -$16M -$30M -$53M -$72M --
Operating Expenses $869M $799M $638M $466M $432M
Operating Income $889M $244M -$459M $340M $792M
 
Net Interest Expenses $66M $68M $98M $99M $59M
EBT. Incl. Unusual Items $704M $84M -$682M $243M $1.3B
Earnings of Discontinued Ops. -- -- -- $340M --
Income Tax Expense $94M $57M $3M $90M $155M
Net Income to Company $610M $27M -$685M $493M $1.2B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $610M $27M -$685M $151M $1.2B
 
Basic EPS (Cont. Ops) $1.97 $0.09 -$2.17 $1.42 $3.34
Diluted EPS (Cont. Ops) $1.93 $0.08 -$2.17 $1.37 $3.07
Weighted Average Basic Share $310M $316M $323M $344M $345M
Weighted Average Diluted Share $316M $319M $323M $357M $376M
 
EBITDA $1.1B $460M -$312M $475M $880M
EBIT $889M $244M -$459M $340M $792M
 
Revenue (Reported) $5.1B $3.7B $2.8B $2.2B $2.8B
Operating Income (Reported) $889M $244M -$459M $340M $792M
Operating Income (Adjusted) $889M $244M -$459M $340M $792M
Period Ending 2021-06-30 2022-06-30 2023-06-30 2024-06-30 2025-06-30
Cash and Equivalents $3.4B $2.3B $2B $1.6B $2.5B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $2.3B $2.8B $1.6B $1.2B $1.5B
Inventory $3.6B $3.6B $3.7B $1.4B $1.3B
Prepaid Expenses -- -- -- -- --
Other Current Assets $514M $684M $567M $673M $965M
Total Current Assets $9.8B $9.5B $7.9B $8.1B $5.9B
 
Property Plant And Equipment $3.4B $4B $3.9B $2.5B $2.5B
Long-Term Investments $1.6B $1.4B $1.4B -- --
Goodwill $10.1B $10B $10B $10B $4.3B
Other Intangibles $442M $213M $80M $78M --
Other Long-Term Assets $1.1B $1.5B $1.5B $1.9B $1.5B
Total Assets $26.1B $26.3B $24.5B $24.2B $14B
 
Accounts Payable $2.3B $2.2B $1.6B $1.1B $1.3B
Accrued Expenses $1.4B $1.6B $1.3B $1.5B $719M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $4.9B $5.2B $5.4B $6.1B $5.4B
 
Long-Term Debt $8.7B $7.3B $7B $6B $2.8B
Capital Leases -- -- -- -- --
Total Liabilities $15.4B $14B $13.6B $13.4B $8.7B
 
Common Stock $3M $3M $3M $3M $3M
Other Common Equity Adj -$197M -$554M -$548M -$712M --
Common Equity $10.7B $12.2B $11B $10.8B $5.3B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $10.7B $12.2B $11B $10.8B $5.3B
 
Total Liabilities and Equity $26.1B $26.3B $24.5B $24.2B $14B
Cash and Short Terms $3.4B $2.3B $2B $1.6B $2.5B
Total Debt $8.9B $7.3B $8.2B $7.8B $5.1B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Cash and Equivalents $3.3B $2B $2B $1.7B $3B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $2.4B $2.4B $1.5B $2.5B $1.4B
Inventory $3.5B $3.9B $3.5B $3.4B $1.4B
Prepaid Expenses -- -- -- -- --
Other Current Assets $576M $738M $597M $798M --
Total Current Assets $9.9B $9.1B $7.6B $8.9B $6.3B
 
Property Plant And Equipment $3.6B $4B $3.8B $3.2B $2.5B
Long-Term Investments $1.6B $1.2B $1.2B $1.1B --
Goodwill $10.1B $10B $10B $9.8B --
Other Intangibles $364M $174M $80M $77M --
Other Long-Term Assets $1.2B $1.5B $1.7B $2B --
Total Assets $26.4B $25.7B $24B $24.8B $14.4B
 
Accounts Payable $2.3B $2B $1.6B $1.9B $1.5B
Accrued Expenses $1.6B $1.6B $1.3B $1.3B --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- $110M --
Total Current Liabilities $4.7B $5B $5.8B $6.1B $5.2B
 
Long-Term Debt $8.6B $7.3B $7.1B $6.2B $2.8B
Capital Leases -- -- -- -- --
Total Liabilities $15B $13.6B $13.9B $13.1B $8.5B
 
Common Stock $3M $3M $3M $3M $3M
Other Common Equity Adj -$167M -$694M -$599M -$400M --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -$3M -- --
Minority Interest, Total -- -- -- -- --
Total Equity $11.4B $12.1B $10.1B $11.6B $5.9B
 
Total Liabilities and Equity $26.4B $25.7B $24B $24.8B $14.4B
Cash and Short Terms $3.3B $2B $2B $1.7B $3B
Total Debt $8.8B $7.3B $8.9B $7.9B $5B
Period Ending 2021-06-30 2022-06-30 2023-06-30 2024-06-30 2025-06-30
Net Income to Stockholders $821M $1.5B -$1.7B -$798M $1.9B
Depreciation & Amoritzation $1.2B $929M $828M $347M $336M
Stock-Based Compensation $318M $326M $318M $295M $265M
Change in Accounts Receivable $121M -$546M $1.2B -$568M $79M
Change in Inventories -$546M -$22M -$60M $356M -$409M
Cash From Operations $1.9B $1.9B -$408M -$294M $1.9B
 
Capital Expenditures $1.1B $1.1B $821M $487M $412M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$765M -$1.2B -$762M -$27M -$25M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- $44M
Special Dividend Paid
Long-Term Debt Issued -- $1.9B $1.2B $3B $56M
Long-Term Debt Repaid -$886M -$3.6B -$1.2B -$2.6B --
Repurchase of Common Stock -- -- -- -- $149M
Other Financing Activities -$65M -$113M -$99M -$279M -$1.4B
Cash From Financing -$817M -$1.7B $875M $187M -$1.6B
 
Beginning Cash (CF) $3.4B $2.3B $2B $1.6B $2.1B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $322M -$1B -$304M -$144M $235M
Ending Cash (CF) $3.7B $1.3B $1.7B $1.4B $2.4B
 
Levered Free Cash Flow $752M $758M -$1.2B -$781M $1.5B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $610M $27M -$685M $493M $1.2B
Depreciation & Amoritzation $250M $216M $147M $135M $88M
Stock-Based Compensation $76M $86M $77M $84M $53M
Change in Accounts Receivable -$188M $382M $147M -$292M $131M
Change in Inventories $73M -$224M $201M -$76M -$101M
Cash From Operations $521M $6M -$626M $34M $672M
 
Capital Expenditures $245M $320M $124M $96M $73M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$312M -$224M $84M -$45M -$57M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- $39M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $300M $600M $150M --
Long-Term Debt Repaid -$213M -$300M -- -$188M --
Repurchase of Common Stock -- -- $3M -- $553M
Other Financing Activities -$78M -$50M -$43M -$64M --
Cash From Financing -$289M -$50M $554M -$102M -$678M
 
Beginning Cash (CF) $3.3B $2B $2B $1.7B $2B
Foreign Exchange Rate Adjustment -- -$10M -$3M $10M -$3M
Additions / Reductions -$80M -$278M $9M -$103M -$66M
Ending Cash (CF) $3.2B $1.8B $2B $1.6B $2B
 
Levered Free Cash Flow $276M -$314M -$750M -$62M $599M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $1.5B $917M -$2.4B $380M $2.6B
Depreciation & Amoritzation $1.1B $895M $759M $335M $289M
Stock-Based Compensation $318M $336M $309M $302M $234M
Change in Accounts Receivable -$349M $24M $971M -$1B $502M
Change in Inventories -$188M -$319M $365M $79M -$434M
Cash From Operations $2.1B $1.4B -$1B $366M $2.5B
 
Capital Expenditures $1.1B $1.2B $625M $459M $389M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$911M -$1.1B -$454M -$156M -$37M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- $83M
Special Dividend Paid
Long-Term Debt Issued -- $2.2B $1.5B $2.6B --
Long-Term Debt Repaid -$886M -$3.7B -$880M -$2.8B --
Repurchase of Common Stock -- -- $3M -$3M $702M
Other Financing Activities -$102M -$85M -$92M -$300M --
Cash From Financing -$853M -$1.5B $1.5B -$469M -$2.2B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $295M -$1.2B -$17M -$256M $272M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $1B $168M -$1.7B -$93M $2.1B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $610M $27M -$685M $493M $1.2B
Depreciation & Amoritzation $250M $216M $147M $135M $88M
Stock-Based Compensation $76M $86M $77M $84M $53M
Change in Accounts Receivable -$188M $382M $147M -$292M $131M
Change in Inventories $73M -$224M $201M -$76M -$101M
Cash From Operations $521M $6M -$626M $34M $672M
 
Capital Expenditures $245M $320M $124M $96M $73M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$312M -$224M $84M -$45M -$57M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- $39M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $300M $600M $150M --
Long-Term Debt Repaid -$213M -$300M -- -$188M --
Repurchase of Common Stock -- -- $3M -- $553M
Other Financing Activities -$78M -$50M -$43M -$64M --
Cash From Financing -$289M -$50M $554M -$102M -$678M
 
Beginning Cash (CF) $3.3B $2B $2B $1.7B $2B
Foreign Exchange Rate Adjustment -- -$10M -$3M $10M -$3M
Additions / Reductions -$80M -$278M $9M -$103M -$66M
Ending Cash (CF) $3.2B $1.8B $2B $1.6B $2B
 
Levered Free Cash Flow $276M -$314M -$750M -$62M $599M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
56
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Sell
50
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
69
RGC alert for Jan 7

Regencell Bioscience Holdings Ltd. [RGC] is up 58.95% over the past day.

Buy
69
WDC alert for Jan 7

Western Digital Corp. [WDC] is down 8.88% over the past day.

Buy
75
DRUG alert for Jan 7

Bright Minds Biosciences, Inc. [DRUG] is up 2.99% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock